top of page

Home
About PBG
- Our Facility
- Our Science
Our Services
- Product Development
- Manufacturing
Contact
Blog
More

Use tab to navigate through the menu items.

All Posts
Press Releases
In the News

PBG BioPharma Inc. announces its lead drug candidate ProZ001 is being used in a groundbreaking phase II, randomized, double-blind, placebo-controlled, cross-over trial

PBG BioPharma Inc. announces its lead drug candidate ProZ001 is being used in a groundbreaking phase II, randomized, double-blind, placebo-controlled, cross-over trial

PBG BioPharma Inc. announces its lead drug candidate ProZ001 is being used in a groundbreaking phase II, randomized, double-blind, placebo-controlled, cross-over trial

Apr 11, 20242 min read

106

PBG BioPharma Inc. Announces the launch of a Phase 2/3 Clinical Trial on its Cannabinoid-based Drug Product ProZ-001 as an Adjunctive Therapy for Acute Bipolar Depression

PBG BioPharma Inc. Announces the launch of a Phase 2/3 Clinical Trial on its Cannabinoid-based Drug Product ProZ-001 as an Adjunctive Therapy for Acute Bipolar Depression

PBG BioPharma Inc. Announces the launch of a Phase 2/3 Clinical Trial on its Cannabinoid-based Drug Product ProZ-001 as an Adjunctive Therapy for Acute Bipolar Depression

Feb 28, 20243 min read

206

PBG BioPharma Inc. Successfully Files Cannabinoid Master Drug File to Health Canada

PBG BioPharma Inc. Successfully Files Cannabinoid Master Drug File to Health Canada

PBG BioPharma Inc. Successfully Files Cannabinoid Master Drug File to Health Canada

Feb 13, 20232 min read

85

PBG NEWS

Subscribe to our newsletters

Thanks for subscribing!

Work Inquiries

Interested in working with us?

info@pbgbiopharma.com

Call Us

Find Out More

Terms and Conditions

© 2024, Copyright PBG BioPharma®

All rights reserved.

CANNABIS MANUFACTURING AND RESEARCH

MEDICAL CANNABIS

Home
About PBG
- Our Facility
- Our Science
Our Services
- Product Development
- Manufacturing
Contact
Blog

Contacts below

Interested in working with us?

info@pbgbiopharma.com

Call Us

Social

bottom of page